CD160 and breast cancer: Similar to CD4+ T cells, DP CD8+ T cells exhibit higher expression of 2B4, PD-1, TIGIT, and CD160 than DN counterparts, and except for TIGIT expression, no differences were detected between DP CD8+T from BC patients and HDs (Supplementary Figures S4B, C).